Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-024463
Filing Date
2025-09-12
Accepted
2025-09-12 20:00:09
Documents
1
Period of Report
2025-09-11

Document Format Files

Seq Description Document Type Size
1 form4-09122025_080904.html 4  
1 form4-09122025_080904.xml 4 9047
  Complete submission text file 0001415889-25-024463.txt   10500
Mailing Address C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL STREET EMERYVILLE CA 94608
Business Address
Brege Laura (Reporting) CIK: 0001365619 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38981 | Film No.: 251312879

Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Issuer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)